SYNERON MEDICAL LTD's ticker is ELOS and the CUSIP is M87245102. A total of 65 filers reported holding SYNERON MEDICAL LTD in Q3 2016. The put-call ratio across all filers is - and the average weighting 0.9%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2017 | $4,498,000 | +26.0% | 426,370 | +0.3% | 1.14% | +32.0% |
Q4 2016 | $3,571,000 | +17.5% | 425,170 | +0.1% | 0.87% | +14.2% |
Q3 2016 | $3,040,000 | -5.5% | 424,570 | +1.5% | 0.76% | -10.6% |
Q2 2016 | $3,217,000 | +16.9% | 418,370 | +11.1% | 0.85% | +24.0% |
Q1 2016 | $2,752,000 | -10.8% | 376,500 | -5.9% | 0.68% | +2.2% |
Q4 2015 | $3,084,000 | +7.8% | 400,000 | 0.0% | 0.67% | +11.5% |
Q3 2015 | $2,860,000 | -32.7% | 400,000 | 0.0% | 0.60% | -20.7% |
Q2 2015 | $4,248,000 | -14.2% | 400,000 | 0.0% | 0.76% | -13.4% |
Q1 2015 | $4,952,000 | +32.7% | 400,000 | 0.0% | 0.87% | +28.2% |
Q4 2014 | $3,732,000 | -6.9% | 400,000 | 0.0% | 0.68% | -8.5% |
Q3 2014 | $4,008,000 | -2.9% | 400,000 | 0.0% | 0.74% | +6.9% |
Q2 2014 | $4,128,000 | -17.1% | 400,000 | 0.0% | 0.70% | -12.5% |
Q1 2014 | $4,980,000 | +1.2% | 400,000 | 0.0% | 0.80% | -2.2% |
Q4 2013 | $4,920,000 | +50.2% | 400,000 | +5.3% | 0.82% | +27.3% |
Q3 2013 | $3,276,000 | +13.4% | 380,000 | +14.5% | 0.64% | -1.4% |
Q2 2013 | $2,888,000 | – | 332,000 | – | 0.65% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Acrospire Investment Management LLC | 2,738 | $30,000 | 90.91% |
BRANDES INVESTMENT PARTNERS, LP | 2,901,971 | $31,921,000 | 0.65% |
Lapides Asset Management, LLC | 186,200 | $2,044,000 | 0.42% |
GARDNER LEWIS ASSET MANAGEMENT L P | 51,703 | $569,000 | 0.04% |